Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.

Article  CAS  PubMed  Google Scholar 

Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.

Article  CAS  PubMed  Google Scholar 

Group CR, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897–908.

Article  Google Scholar 

Tsai ASH, Cheung N, Gan ATL, Jaffe GJ, Sivaprasad S, Wong TY, et al. Retinal angiomatous proliferation. Surv Ophthalmol. 2017;62:462–92.

Article  PubMed  Google Scholar 

Yoneyama S, Sakurada Y, Mabuchi F, Imasawa M, Sugiyama A, Kubota T, et al. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2014;252:1435–41.

Article  CAS  PubMed  Google Scholar 

Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, et al. Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol. 2019;63:374–81.

Article  CAS  PubMed  Google Scholar 

Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, et al. Outcomes in eyes with retinal angiomatous proliferation in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2016;123:609–16.

Article  PubMed  Google Scholar 

Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis. Int Ophthalmol. 2017;37:1397–409.

Article  PubMed  Google Scholar 

Shijo T, Sakurada Y, Yoneyama S, Sugiyama A, Kikushima W, Tanabe N, et al. Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255:1125–31.

Article  CAS  PubMed  Google Scholar 

Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment. Graefes Arch Clin Exp Ophthalmol. 2019;257:1183–9.

Article  CAS  PubMed  Google Scholar 

Saito M, Itagaki K, Sekiryu T. Fundus autofluorescence of retinal angiomatous proliferation. PLoS ONE. 2020;15: e0243458. https://doi.org/10.1371/journal.pone.0243458.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fallico M, Macchi I, Maugeri A, Favara G, Barchitta M, Magnano San Lio R, et al. Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis. Front Pharmacol. 2023;14:1141077.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakurada Y, Yoneyama S, Sugiyama A, Tanabe N, Kikushima W, Mabuchi F, et al. Prevalence and genetic characteristics of geographic atrophy among elderly Japanese with age-related macular degeneration. PLoS ONE. 2016;11: e0149978. https://doi.org/10.1371/journal.pone.0149978.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuroda Y, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Oishi A, et al. Retinal pigment epithelial atrophy in neovascular age-related macular degeneration after ranibizumab treatment. Am J Ophthalmol. 2016;161(94–103): e1.

Google Scholar 

Hata M, Yamashiro K, Oishi A, Ooto S, Tamura H, Miyata M, et al. Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor injections for retinal angiomatous proliferation. Retina. 2017;37:2069–77.

Article  CAS  PubMed  Google Scholar 

Matsumoto H, Sato T, Morimoto M, Mukai R, Takahashi M, Hiroe T, et al. Treat-and-extend regimen with aflibercept for retinal angiomatous proliferation. Retina. 2016;36:2282–9.

Article  CAS  PubMed  Google Scholar 

Grunwald JE, Pistilli M, Daniel E, Ying GS, Pan W, Jaffe GJ, et al. Incidence and growth of geographic atrophy during 5 years of comparison of age-related macular degeneration treatments trials. Ophthalmology. 2017;124:97–104.

Article  PubMed  Google Scholar 

Cho HJ, Yoo SG, Kim HS, Kim JH, Kim CG, Lee TG, et al. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol. 2015;159(285–92): e1.

Google Scholar 

Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.

Article  CAS  PubMed  Google Scholar 

McBain VA, Kumari R, Townend J, Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina. 2011;31:1043–52.

Article  PubMed  Google Scholar 

Cho HJ, Lim SH, Kim J, Lee J, Lee DW, Kim JW. Assessing the long-term evolution of type 3 neovascularization in age-related macular degeneration using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2021;259:2605–13.

Article  CAS  PubMed  Google Scholar 

Baek J, Lee JH, Kim JY, Kim NH, Lee WK. Geographic atrophy and activity of neovascularization in retinal angiomatous proliferation. Invest Ophthalmol Vis Sci. 2016;57:1500–5.

Article  CAS  PubMed  Google Scholar 

Kim JH, Kim JW, Kim CG, Lee DW. Long-term treatment outcomes in type 3 neovascularization: focus on the difference in outcomes between geographic atrophy and fibrotic scarring. J Clin Med. 2020;9:1145.

Article  PubMed  PubMed Central  Google Scholar 

Maruyama-Inoue M, Sato S, Yamane S, Kadonosono K. Predictive factors and long-term visual outcomes after anti-vascular endothelial growth factor treatment of retinal angiomatous proliferation. Clin Ophthalmol. 2019;13:1981–9.

Article  PubMed  PubMed Central  Google Scholar 

Browning AC, Grinton ME, Quinn S, Jain T, Manikavasagar V, Aftab AM. Long term follow up of patients with MNV3 treated with intra-vitreal Aflibercept. Eur J Ophthalmol. 2024;34:1562–8.

Article  PubMed  Google Scholar 

Kikushima W, Sakurada Y, Fukuda Y, Matsubara M, Yoneyama S, Shijo T, et al. Incidence and characteristics of neovascular age-related macular with over a 12-month remission after three monthly aflibercept administration: 60 Months Results of a Pro Re Nata Regimen. Retina. 2024;44:498–505.

CAS  PubMed  Google Scholar 

Rouvas AA, Chatziralli IP, Theodossiadis PG, Moschos MM, Kotsolis AI, Ladas ID. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina. 2012;32:1181–9.

Article  CAS  PubMed  Google Scholar